RUNX2 and breast carcinoma: The osteomimetism of breast cancer cells has been studied by targeting a panel of proteins expressed by bone cells including the transcription factor RUNX2 (Runt-related transcription factor), involved in skeletal development, osteoblast proliferation and differentiation, bone matrix synthesis, and the bone matrix proteins osteopontin (OPN), osteocalcin (OC) and bone sialoprotein (BSP) [26, 27].